Additionally, focal deletions targeting the RBMY gene family (RBMY1A1, RBMY1B, RBMY1D)—male germ cell–specific RNA-binding proteins—were significantly enriched in seminomas (26.6% vs. 12.8% in non-seminomas; P = 0.0078). The gene discussed is RBMY1D; the disease is seminoma.